Advertisement
U.S. markets open in 8 hours 37 minutes

Astellas Pharma Inc. (ALPMF)

Other OTC - Other OTC Delayed Price. Currency in USD
11.31+0.57 (+5.31%)
At close: 10:31AM EDT
  • Dividend

    ALPMF announced a cash dividend of 35.00 with an ex-date of Mar. 28, 2024

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close10.74
Open11.31
Bid0.00 x 0
Ask0.00 x 0
Day's Range11.31 - 11.31
52 Week Range10.62 - 17.00
Volume925
Avg. Volume3,480
Market Cap20.279B
Beta (5Y Monthly)0.28
PE Ratio (TTM)565.50
EPS (TTM)0.02
Earnings DateN/A
Forward Dividend & Yield0.52 (4.64%)
Ex-Dividend DateMar 28, 2024
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for ALPMF

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • ASTELLAS PHARMA
    Analyst Report: Merck KGaAMerck KGaA operates in three main segments: life sciences, performance materials, and healthcare. The life sciences segment (47% of 2022 sales) primarily provides laboratory consumables and services to researchers in academia and applied fields, including the biopharmaceutical industry. In the healthcare segment (35%), Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In its electronics segment (18%), the company offers specialty materials to manufacture a variety of products, such as semiconductors, flat-screen televisions, automobiles, and cosmetics. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.
    Rating
    Fair Value
    Economic Moat
    12 days agoMorningstar
View more